Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.95%12.13B | 44.99%4.49B | 21.65%2.68B | -8.16%2.39B | 7.92%2.57B | -5.32%10.29B | 10.58%3.1B | 6.79%2.2B | -17.68%2.6B | -16.05%2.38B |
Cost of revenue | 17.54%9.34B | 47.11%3.41B | 18.76%2.03B | -8.19%1.83B | 7.57%2.07B | -6.89%7.94B | 10.61%2.32B | 9.41%1.71B | -21.05%2B | -18.11%1.92B |
Gross profit | 19.35%2.79B | 38.71%1.09B | 31.73%645.67M | -8.06%557.62M | 9.37%503.94M | 0.43%2.34B | 10.49%783.39M | -1.44%490.14M | -4.21%606.53M | -6.22%460.79M |
Operating expense | 4.91%2.23B | 4.75%570.74M | 4.86%569.38M | 4.52%522.45M | 5.50%562.91M | 1.89%2.12B | -0.52%544.87M | 3.86%543M | 2.80%499.86M | 1.60%533.58M |
Staff costs | 6.24%1.45B | 9.76%549.57M | 5.46%317.53M | 4.29%292.59M | 2.74%287.88M | 2.76%1.36B | 0.99%500.69M | 1.75%301.09M | 2.52%280.56M | 7.55%280.19M |
Selling and administrative expenses | 1.21%133.95M | ---- | ---- | ---- | ---- | 54.25%132.34M | ---- | ---- | ---- | ---- |
-Selling and marketing expense | -38.56%21.37M | ---- | ---- | ---- | ---- | 82.96%34.77M | ---- | ---- | ---- | ---- |
-General and administrative expense | 15.39%112.58M | ---- | ---- | ---- | ---- | 46.08%97.57M | ---- | ---- | ---- | ---- |
Depreciation and amortization | -39.55%33.79M | ---- | ---- | ---- | ---- | -18.05%55.9M | ---- | ---- | ---- | ---- |
-Depreciation | -9.42%33.79M | ---- | ---- | ---- | ---- | -6.86%37.31M | ---- | ---- | ---- | ---- |
-Amortization | --0 | ---- | ---- | ---- | ---- | -33.97%18.59M | ---- | ---- | ---- | ---- |
Rent and land expenses | -0.46%122.93M | ---- | ---- | ---- | ---- | -13.34%123.5M | ---- | ---- | ---- | ---- |
Other operating expenses | 9.00%487.25M | -0.72%-269.49M | 4.11%251.86M | 4.82%229.86M | 8.54%275.03M | -2.72%447.04M | -9.38%-267.56M | 6.61%241.92M | 3.15%219.3M | -4.25%253.39M |
Operating profit | 158.89%568.36M | 116.28%515.86M | 244.31%76.29M | -67.03%35.17M | 18.99%-58.97M | -11.80%219.54M | 47.86%238.52M | -107.24%-52.87M | -27.41%106.67M | -115.14%-72.79M |
Net non-operating interest income (expenses) | -4.28%-4.19M | 1,120.25%1.93M | 103.08%67K | -4,157.89%-4.63M | 26.43%-1.56M | 5.86%-4.02M | -61.27%158K | -197.93%-2.17M | 102.64%114K | 17.61%-2.12M |
Non-operating interest income | -50.87%85K | -91.67%6K | -93.06%5K | -45.83%13K | 1,120.00%61K | 592.00%173K | 1,100.00%72K | 1,100.00%72K | 242.86%24K | -16.67%5K |
Non-operating interest expense | 2.01%4.27M | -2,134.88%-1.92M | -102.76%-62K | 5,254.44%4.64M | -23.73%1.62M | -2.38%4.19M | 78.61%-86K | 201.45%2.24M | -102.08%-90K | -17.61%2.12M |
Net investment income | -3.81%4.14M | 201.32%2.73M | 589.05%4.4M | -273.83%-3.05M | -94.43%56K | 111.47%4.3M | 99.12%906K | -25.70%639K | 104.34%1.75M | -35.70%1.01M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | -80.46M | 0 | |||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 65.14%-1.63M | 0 | 0 | 50.56%-4.68M | -716.69%-4.69M | -238.64%-61K | ||||
Less:Other special charges | -65.14%1.63M | --0 | --0 | ---- | ---- | -50.56%4.68M | ---- | ---- | ---- | ---- |
Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 569.23%61K | ---- | ---- |
Other non-operating income (expenses) | -8,041.68%-52.02M | -30,225.71%-52.72M | -185.21%-265K | 48.15%-14K | 400.51%981K | 123.68%655K | 112.95%175K | 294.38%311K | 96.96%-27K | 153.26%196K |
Income before tax | 280.26%514.66M | 99.01%467.8M | 159.80%80.49M | -76.20%25.85M | 19.29%-59.48M | -30.56%135.34M | 45.47%235.06M | -496.97%-134.61M | 7.28%108.59M | -62.52%-73.7M |
Income tax | 92.81%131.89M | 369.20%45.47M | 50.13%45.58M | 156.81%8.2M | -52.95%32.64M | 23.84%68.4M | 3.52%-16.89M | 451.81%30.36M | -178.43%-14.44M | 10.18%69.37M |
Net income | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M | -32.09%-143.08M |
Net income continuous operations | 471.81%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.16%-164.96M | 48.55%123.03M | -32.09%-143.08M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M | -32.09%-143.08M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M | -32.09%-143.08M |
Gross dividend payment | ||||||||||
Basic earnings per share | 471.56%25.32 | 67.61%27.94 | 121.17%2.31 | -85.73%1.16 | 35.62%-6.09 | -52.06%4.43 | 40.68%16.67 | -1,085.87%-10.91 | 48.63%8.13 | -32.12%-9.46 |
Diluted earnings per share | 471.56%25.32 | 67.63%27.9331 | 121.17%2.3095 | -85.73%1.16 | 35.62%-6.09 | -52.06%4.43 | 40.69%16.6636 | -1,085.18%-10.9106 | 48.63%8.13 | -32.12%-9.46 |
Dividend per share | 66.67%5 | 66.67%5 | 0 | 0 | 0 | 0.00%3 | 0.00%3 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |